Literature DB >> 29420980

MR Imaging for Prostate Cancer Screening and Active Surveillance.

Sasha C Druskin1, Katarzyna J Macura2.   

Abstract

The current prostate cancer management paradigm has been criticized in recent years for contributing to the overdiagnosis and overtreatment of the disease. Active surveillance is an avenue by which to reduce overtreatment, but patient selection and monitoring remain a challenge. The use of prostate MR imaging has been growing in recent years and has been incorporated into prostate cancer screening and patient selection and monitoring for active surveillance. This review article discusses the current evidence for the use of MR imaging in each of those settings.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Active surveillance; Biopsy; Cancer screening; MR imaging; Prostate cancer

Mesh:

Year:  2017        PMID: 29420980     DOI: 10.1016/j.rcl.2017.10.006

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  4 in total

1.  Functional outcomes of robot-assisted radical prostatectomy in patients eligible for active surveillance.

Authors:  Marc Zanaty; Khaled Ajib; Kevin Zorn; Assaad El-Hakim
Journal:  World J Urol       Date:  2018-04-21       Impact factor: 4.226

2.  Analysis of Magnetic Resonance Image Signal Fluctuations Acquired During MR-Guided Radiotherapy.

Authors:  Adrian L Breto; Kyle R Padgett; John C Ford; Deukwoo Kwon; Channing Chang; Martin Fuss; Radka Stoyanova; Eric A Mellon
Journal:  Cureus       Date:  2018-03-28

3.  Tumor-Activatable Clinical Nanoprobe for Cancer Imaging.

Authors:  Derek Reichel; Manisha Tripathi; Pramod Butte; Rola Saouaf; J Manuel Perez
Journal:  Nanotheranostics       Date:  2019-05-04

4.  Multiparametric Magnetic Resonance Imaging, 68Ga Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography, and Respective Quantitative Parameters in Detection and Localization of Clinically Significant Prostate Cancer in Intermediate- and High-Risk Group Patients: An Indian Demographic Study.

Authors:  Vijay Kubihal; Sanjay Sharma; Rakesh Kumar; Amlesh Seth; Rajeev Kumar; Seema Kaushal; Jayati Sarangi; Ravikant Gupta; Chandan Jyoti Das
Journal:  Indian J Nucl Med       Date:  2021-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.